Betnovate, Crème

7680309680269 CH-30968 Crème

Associated product:

BETNOVATE crème tb 30 g
Betnovate, Crème
Betnovate, Crème
Betnovate, Crème
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
g
Galenic form
Crème
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
72.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 12.75
Specialties list
Yes
Generic
No
SL addition date: 15/03/1965

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
30968
Drug name
Betnovate, Crème
Galenic form
CREM
ATC Code
D07AC01
Authorization status
Z
Dispensing category
B
First authorization
16/10/1964
Authorization expiration date
31/12/9999
IT Number
10.05.1.
Domain
Human medicine
Field of application
Entzündliche, nicht infizierte Dermatosen

Package details

Description (FR)
BETNOVATE crème tb 30 g
Description (DE)
BETNOVATE Creme Tb 30 g
Market launch
16/10/1964
Narcotic (BTM)
No

Other package sizes (2)

BETNOVATE crème tb 15 g
None None
GTIN: 7680309680184
Not in V1
BETNOVATE crème 50 g
None None
GTIN: 7680309680344
Not in V1